This CE activity was originally published in The Rx Consultant. If you received credit for it previously, you cannot receive credit for it again.
More than 50 years after the landmark 1964 Surgeon General’s Report on the health consequences of smoking, an estimated 15% of adult Americans still smoke. Smoking remains the leading cause of preventable death in the United States – accounting for 480,000 deaths per year (1 of every 5). People who quit smoking greatly reduce their risk for tobacco-related diseases, including cancer, heart disease, and lung disease, while also increasing life expectancy and improving quality of life. Each year, the economic costs due to tobacco use, including direct medical care and lost productivity, exceed $289 billion. For each pack of cigarettes sold, the societal costs due to smoking-related health care costs and lost productivity are estimated at $19.16 per pack, nearly 3 times the average cost of a pack of cigarettes ($6.16).
The good news is that 68% of all adults who smoke want to quit. Effective treatments are available—medications, behavioral counseling, or both—with successful quit rates of around 20-37% at least 6 months after quitting. However, most patients attempt to quit unassisted (without using proven cessation treatments). During 2015 only about one third of smokers used behavioral counseling and/or medications to assist them when trying to quit.
Over the past several years, research has guided our clinical approach to treating tobacco use and dependence. When used correctly, the FDA-approved medications for smoking cessation approximately double the likelihood of quitting. Further benefit is seen when medications are combined with behavioral counseling. Although more intensive interventions provide higher quit rates, even brief advice from healthcare providers—as few as 3 minutes—has been shown to have an impact on patients’ likelihood of quitting...
- Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, and Registered Nurses
This CE activity was developed by The Rx Consultant, a publication of Continuing Education Network, Inc.
CE activities for Pharmacists and Pharmacy Technicians:
This continuing education (CE) activity meets the requirements of all state boards of pharmacy for approved continuing education hours. CE credit is automatically reported to CPE Monitor.
CE activities for Nurse Practitioners and Clinical Nurse Specialists:
This continuing education activity meets the requirements of:
The American Nurses Credentialing Center (ANCC) for formally approved continuing education (CE) hours, and CE hours of pharmacotherapeutics.
The American Academy of Nurse Practitioners Certification Program (AANPCP) for acceptable, accredited CE.
This is a pharmacotherapeutics/pharmacology CE activity.
Continuing Education Network, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Requirements for CE Credit
- Discuss tobacco dependence and the symptoms of withdrawal from nicotine.
- List the 5 key components of comprehensive smoking cessation counseling. Apply the abbreviated “Ask-Advise-Refer” counseling approach. Be familiar with smoking cessation resources for patient referral.
- Assist patients with smoking cessation product selection and dosing based on tobacco use history. Discuss the advantages and disadvantages of each product. Describe the types of patients who might benefit from combination therapy.
- Discuss the contraindications and potential adverse effects of the FDA-approved medications for smoking cessation.
Karen Suchanek Hudmon, DrPH, MS, RPh
Brief Bio : Karen Hudmon,DrPH, MS, RPh, Professor of Pharmacy Practice Department of Pharmacy Practice, Purdue University College of Pharmacy. Specialties:public health pharmacy, cancer prevention research.
Disclosure : Dr. Hudmon reports no financial or personal relationship with any commercial interest producing, marketing, reselling, or distributing a product or service that appears in this issue.
Lisa A. Kroon, PharmD
Brief Bio : Lisa A. Kroon, PharmD, Professor of Clinical Pharmacy, Department of Clinical Pharmacy, School of Pharmacy,University of california, San Francisco. Specialties: tobacco cessation, diabetes, community pharmacy practice.
Disclosure : Dr. Kroon reports no financial or personal relationship with any commercial interest producing, marketing, reselling, or distributing a product or service that appears in this issue.
Robin L. Corelli
Brief Bio : Robin L. Corelli, PharmD, Professor of Clinical Pharmacy, Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco. Specialties: tobacco cessation, community pharmacy practice.
Disclosure : Dr. Corelli ,reports no financial or personal relationship with any commercial interest producing, marketing, reselling, or distributing a product or service that appears in this issue.